NCT04079322 is a NA clinical trial of Meal in Iron-deficiency, sponsored by Florida State University.

Who is sponsoring NCT04079322?

NCT04079322 is sponsored by Florida State University.

What drugs are being tested in NCT04079322?

Interventions in NCT04079322: Meal.

What condition does NCT04079322 study?

NCT04079322 studies Iron-deficiency, Iron Deficiency Anemia.

Is NCT04079322 still recruiting?

NCT04079322 is currently completed. Last updated 27 February 2020.

Last reviewed 2020-02-27 · How we verify

NCT04079322

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Iron Absorption and Exercise

Completed NA Last updated 27 February 2020

What this trial tests

NA trial testing Meal in Iron-deficiency in 31 participants. Completed in 4 December 2019.

Timeline

22 August 2019

Primary endpoint
4 December 2019

4 December 2019

Quick facts

Lead sponsor	Florida State University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	crossover
Masking	none
Primary purpose	basic science
Enrollment	31
Start date	22 August 2019
Primary completion	4 December 2019
Estimated completion	4 December 2019
Sites	1 location across United States

Drugs / interventions tested

Meal

Conditions studied

Iron-deficiency — all drugs for Iron-deficiency →
Iron Deficiency Anemia — all drugs for Iron Deficiency Anemia →

Sponsor

Florida State University

Who can join

Eligibility, any sex, with Iron-deficiency or Iron Deficiency Anemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Iron is a nutritionally essential mineral required for optimal physical and cognitive performance. Endurance exercise often leads to declines in iron status; however, the reason for the decline is not known. The primary objective of the proposed study is to determine the effects of an acute bout of strenuous endurance exercise on iron absorption and status and markers of inflammation in human volunteers. The investigators hypothesize that an acute bout of strenuous endurance exercise, compared to rest, will reduce iron absorption, resulting in diminished iron status, and that reduced iron absorption will be negatively associated with markers of inflammation. A secondary objective is to monitor iron status throughout a season of competition.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

A Prolonged Bout of Running Increases Hepcidin and Decreases Dietary Iron Absorption in Trained Female and Male Runners.
Barney DE, Ippolito JR, Berryman CE, Hennigar SR. · · 2022 · cited 11× · PMID 35661896 · DOI 10.1093/jn/nxac129
Dietary Intake and Diet Quality of Female and Male NCAA Division I Cross Country Runners from a Single University.
Barney DE, Cheung SN, Harris AR, Berryman CE, et al · · 2024 · cited 3× · PMID 39610765 · DOI 10.1016/j.cdnut.2024.104475

Verify or expand the search:

Other trials of Meal

Trials testing the same drug.

NCT07231133 — Effect of Within-Meal Consumption of Allulose on Diet-induced Thermogenesis · NA · completed
NCT06486597 — Whole Body Metabolism in Children With Cerebral Palsy With Low Skeletal Muscle Mass · NA · recruiting
NCT05470218 — Leucine, MTOR and Athero · NA · active not recruiting
NCT05469620 — Adaptive Nutrition Therapy in Hemodialysis · NA · completed
NCT05401552 — Phosphate Bioavailability Hormonal Response to a Breakfast Meal in Healthy Humans · NA · completed

Other recruiting trials for Iron-deficiency

Currently open trials in the same condition.

NCT05407987 — Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery) · Phase 3 · recruiting
NCT06270498 — Effect of Oral sucRosomIal Iron on exerciSE Capacity and Quality of Life in Patients With Heart Failure · Phase 4 · recruiting
NCT05913414 — Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma · Phase 2 · recruiting
NCT05340465 — Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants · Phase 2 · recruiting
NCT07083492 — Non-invasive Detection of Iron Deficiency in Obstetrics · recruiting

Other Florida State University trials

Trials by the same sponsor.

NCT06127914 — Learning Early Infant Feeding Cues · NA · not yet recruiting
NCT06015581 — Scaling Up Implementation Strategies to Improve the DIAGNOSE and PREVENT Pillars for Young MSM in Florida · NA · not yet recruiting
NCT07467473 — Causal Role of Rostromedial Prefrontal Cortex for Positive Savoring in Depression · NA · enrolling by invitation
NCT07221448 — Sodium vs Potassium Education to Improve Vascular Health · NA · recruiting
NCT07415941 — MBM and taVNS for Low Back Pain and Depressive Symptoms · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04079322 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Florida State University
Last refreshed: 27 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04079322.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing